These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 23249450)

  • 61. Metabolic dysfunction in obese Hispanic women with polycystic ovary syndrome.
    Sam S; Scoccia B; Yalamanchi S; Mazzone T
    Hum Reprod; 2015 Jun; 30(6):1358-64. PubMed ID: 25857311
    [TBL] [Abstract][Full Text] [Related]  

  • 62. The predictive effect of inflammatory markers and lipid accumulation product index on clinical symptoms associated with polycystic ovary syndrome in nonobese adolescents and younger aged women.
    Tola EN; Yalcin SE; Dugan N
    Eur J Obstet Gynecol Reprod Biol; 2017 Jul; 214():168-172. PubMed ID: 28535403
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Circulating osteoprotegerin and soluble receptor activator of nuclear factor κB ligand in polycystic ovary syndrome: relationships to insulin resistance and endothelial dysfunction.
    Pepene CE; Ilie IR; Marian I; Duncea I
    Eur J Endocrinol; 2011 Jan; 164(1):61-8. PubMed ID: 20974706
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Clinical and Biochemical Profiles according to Homeostasis Model Assessment-insulin Resistance (HOMA-IR) in Korean Women with Polycystic Ovary Syndrome.
    Lee DE; Park SY; Park SY; Lee SR; Chung HW; Jeong K
    J Menopausal Med; 2014 Dec; 20(3):104-10. PubMed ID: 25580421
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The evaluation of carotid intima-media thickness and visceral obesity as an atherosclerosis predictor in newly-diagnosed polycystic ovary syndrome.
    Buyukkaya R; Besir FH; Yazgan S; Karatas A; Kose SA; Aydin Y; Erdogmus B
    Clin Ter; 2014; 165(1):e6-11. PubMed ID: 24589963
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Lipids and lipoprotein subfractions in women with PCOS: relationship to metabolic and endocrine parameters.
    Pirwany IR; Fleming R; Greer IA; Packard CJ; Sattar N
    Clin Endocrinol (Oxf); 2001 Apr; 54(4):447-53. PubMed ID: 11318779
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Metabolic and Endocrine Characteristics of Indian Women with Polycystic Ovary Syndrome.
    Kumar AN; Naidu JN; Satyanarayana U; Ramalingam K; Anitha M
    Int J Fertil Steril; 2016; 10(1):22-8. PubMed ID: 27123196
    [TBL] [Abstract][Full Text] [Related]  

  • 68. The serum protein α2-Heremans-Schmid glycoprotein/fetuin-a concentration and carotid intima-media thickness in women with polycystic ovary syndrome.
    Abali R; Celik C; Tasdemir N; Guzel S; Alpsoy S; Yuksel A; Celik E
    Eur J Obstet Gynecol Reprod Biol; 2013 Jul; 169(1):45-9. PubMed ID: 23433744
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Omental adipose tissue overexpression of fatty acid transporter CD36 and decreased expression of hormone-sensitive lipase in insulin-resistant women with polycystic ovary syndrome.
    Seow KM; Tsai YL; Hwang JL; Hsu WY; Ho LT; Juan CC
    Hum Reprod; 2009 Aug; 24(8):1982-8. PubMed ID: 19423542
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Echocardiographic evaluation of diastolic functions in patients with polycystic ovary syndrome: A comperative study of diastolic functions in sub-phenotypes of polycystic ovary syndrome.
    Yildirim E; Karabulut O; Yuksel UC; Celik M; Bugan B; Gokoglan Y; Ulubay M; Gungor M; Koklu M
    Cardiol J; 2017; 24(4):364-373. PubMed ID: 28353313
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Carotid intimo-medial thickness: A predictor for cardiovascular disorder in patients with polycystic ovarian syndrome in the South Indian population.
    Garg N; Dharmalingam M; Prabhu V; Murthy NS
    Indian J Endocrinol Metab; 2016; 20(5):662-666. PubMed ID: 27730077
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Advanced oxidation protein products are increased in women with polycystic ovary syndrome: relationship with traditional and nontraditional cardiovascular risk factors in patients with polycystic ovary syndrome.
    Kaya C; Erkan AF; Cengiz SD; Dünder I; Demirel ÖE; Bilgihan A
    Fertil Steril; 2009 Oct; 92(4):1372-1377. PubMed ID: 18976759
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Carotid artery intima-media thickness in polycystic ovary syndrome: a systematic review and meta-analysis.
    Meyer ML; Malek AM; Wild RA; Korytkowski MT; Talbott EO
    Hum Reprod Update; 2012; 18(2):112-26. PubMed ID: 22108382
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Fibroblast growth factor 21 and its relation to metabolic parameters in women with polycystic ovary syndrome.
    Sahin SB; Ayaz T; Cure MC; Sezgin H; Ural UM; Balik G; Sahin FK
    Scand J Clin Lab Invest; 2014 Sep; 74(6):465-9. PubMed ID: 24724557
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Spectrum of metabolic dysfunction in relationship with hyperandrogenemia in obese adolescent girls with polycystic ovary syndrome.
    Alemzadeh R; Kichler J; Calhoun M
    Eur J Endocrinol; 2010 Jun; 162(6):1093-9. PubMed ID: 20371657
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Ultrasonographic and laboratory markers of metabolic and cardiovascular disease risk in obese women with polycystic ovary syndrome.
    Zueff LF; Martins WP; Vieira CS; Ferriani RA
    Ultrasound Obstet Gynecol; 2012 Mar; 39(3):341-7. PubMed ID: 21898634
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Exploration of the classification of polycystic ovarian syndrome].
    Lin JF; Li X; Zhu MW
    Zhonghua Fu Chan Ke Za Zhi; 2006 Oct; 41(10):684-8. PubMed ID: 17199924
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Frequency of nodular goiter and autoimmune thyroid disease and association of these disorders with insulin resistance in polycystic ovary syndrome.
    Karaköse M; Hepsen S; Çakal E; Saykı Arslan M; Tutal E; Akın Ş; Ünsal İ; Özbek M
    J Turk Ger Gynecol Assoc; 2017 Jun; 18(2):85-89. PubMed ID: 28400351
    [TBL] [Abstract][Full Text] [Related]  

  • 79. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY, AND ANDROGEN EXCESS AND PCOS SOCIETY DISEASE STATE CLINICAL REVIEW: GUIDE TO THE BEST PRACTICES IN THE EVALUATION AND TREATMENT OF POLYCYSTIC OVARY SYNDROME - PART 2.
    Goodman NF; Cobin RH; Futterweit W; Glueck JS; Legro RS; Carmina E; ; ;
    Endocr Pract; 2015 Dec; 21(12):1415-26. PubMed ID: 26642102
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Elevated circulating levels of betatrophin are associated with polycystic ovary syndrome.
    Calan M; Yilmaz O; Kume T; Unal Kocabas G; Yesil Senses P; Senses YM; Temur M; Gursoy Calan O
    Endocrine; 2016 Jul; 53(1):271-9. PubMed ID: 26832343
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.